Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kronox Lab SciencesNSE:KRONOX -3.67%43 PB Ratio is 6.02 as of Aug. 28, 2026, which is 3% above its 10-year median of 5.82. GuruFocus rates NSE:KRONOX with a GF Score™ of 43/100. The stock has 3 warning signs investors should review. Among 1,580 Chemicals companies, Kronox Lab Sciences ranks worse than 90% on this metric.
Kronox Lab Sciences Ltd stock PB Ratio (=6.02) is close to 1-year high of 6.02.
The historical rank and industry rank for Kronox Lab Sciences's PB Ratio or its related term are showing as below:
NSE:KRONOX'
s PB Ratio Range Over the Past 10 Years
Min: 3.8 Med: 5.82 Max: 10.2
Current: 6.02
During the past 6 years, Kronox Lab Sciences's highest PB Ratio was 10.20. The lowest was 3.80. And the median was 5.82.
NSE:KRONOX's PB Ratio is ranked worse than 90% of 1580
companies
in the Chemicals industry
Industry Median: 1.75
vs NSE:KRONOX: 6.02
During the past 12 months, Kronox Lab Sciences's average Book Value Per Share Growth Rate was 28.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 37.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 33.60% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Kronox Lab Sciences was 37.50% per year. The lowest was 30.70% per year. And the median was 35.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Kronox Lab Sciences PB Ratio Related Terms
Kronox Lab Sciences PB Ratio Historical Data
* Premium members only.
The historical data trend for Kronox Lab Sciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Kronox Lab Sciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kronox Lab Sciences PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kronox Lab Sciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Kronox Lab Sciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Kronox Lab Sciences (NSE:KRONOX) has a PB Ratio of 6.02 as of Aug. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kronox Lab Sciences and its competitors. This is near median its historical median of 5.82. Over the past decade, Kronox Lab Sciences' PB Ratio has ranged from 3.80 to 10.20. According to the industry distribution chart, Kronox Lab Sciences ranks #1422 out of 1580 companies in the Chemicals industry, placing it in the top 90%.
Is Kronox Lab Sciences' PB Ratio too high?
Kronox Lab Sciences' current PB Ratio of 6.02 is near median its 10-year median of 5.82. Over the past 10 years, this metric has ranged from a low of 3.80 to a high of 10.20. The Chemicals industry median PB Ratio is 1.75. Kronox Lab Sciences' value of 6.02 is 244% above this industry median. Based on the distribution chart, Kronox Lab Sciences ranks #1422 out of 1580 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Kronox Lab Sciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Kronox Lab Sciences' PB Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Kronox Lab Sciences ranks #1422 out of 1580 companies for PB Ratio. This places Kronox Lab Sciences in the lower half of its industry. The industry median PB Ratio is 1.75. Kronox Lab Sciences' value of 6.02 is 244% above this benchmark. Historically, Kronox Lab Sciences' own PB Ratio has ranged from 3.80 to 10.20 over the past decade. While the company's 10-year median is 5.82 vs. the industry median of 1.75, Kronox Lab Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.75, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kronox Lab Sciences's current PB Ratio of 6.02 is 244% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Kronox Lab Sciences and its competitors. For the Chemicals industry, the median PB Ratio is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kronox Lab Sciences's current PB Ratio is 6.02, which is near median its own 10-year median of 5.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kronox Lab Sciences stock overvalued right now?
Kronox Lab Sciences (NSE:KRONOX) has a current PB Ratio of 6.02. The current PB Ratio is 6.02, which is near median its 10-year median of 5.82 and 244% above the Chemicals industry median of 1.75. Kronox Lab Sciences' overall GF Score™ is 43/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Kronox Lab Sciences (NSE:KRONOX), the current PB Ratio is 6.02 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kronox Lab Sciences Ltd manufactures High Purity Speciality Fine Chemicals for diversified end-user industries. The company's Fine inorganic Chemicals are used mainly as reacting agents and raw materials in the manufacturing of Active Pharmaceutical Ingredients; excipients in pharmaceutical formulations; reagents for scientific research and laboratory testing; ingredients in nutraceuticals formulations; process intermediates and fermenting agents in biotech applications; ingredients in agrochemical formulations; ingredients in personal care products; refining agents in metal refineries; and ingredients in animal health products, amongst others.
43GF Score
Get the complete analysis for NSE:KRONOX
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRONOX has been successfully added to your 
